Microvast Q3 loss widens to $76.8M as revenue falls
Microvast Holdings, Inc. reported Q3 2026 revenue of $45.8 million, down 62.8% from $123.3 million in Q3 2025, as sales volume fell 62.2%.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Microvast Holdings, Inc. reported Q3 2026 revenue of $45.8 million, down 62.8% from $123.3 million in Q3 2025, as sales volume fell 62.2%. Gross margin was 5.2%, compared with 37.6% in Q3 2025, and net loss was $76.8 million versus $1.5 million. A $9.3 million obsolete-inventory write-down reduced margin by 20.4 percentage points; $35.7 million of non-cash long-lived-asset impairments and lower gross profit contributed to the quarterly loss.
Liquidity remains a central concern: cash, cash equivalents and restricted cash totaled $124.4 million as of September 30, 2026, while usable cash across entities was approximately $71.3 million as of October 31, 2026. Management expects available cash to be insufficient for obligations over the next 12 months absent additional financing, refinancing or extensions, or further cost cuts; it concluded substantial doubt about its ability to continue as a going concern has not been alleviated. Total debt was $177.0 million as of September 30, 2026, and $41.7 million of convertible bonds were due with accrued interest on or before January 31, 2027. The company is negotiating with lenders, but said there could be no assurance of refinancing or extensions on acceptable terms, or at all.
0 points · 0 major1 major · 3 points
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- None.
Negative
- Major pointGoing-concern substantial doubt remains unalleviated.
- Moderate pointQ3 revenue fell 62.8% year over year to $45.8 million.
- Moderate pointQ3 gross margin fell to 5.2% from 37.6% a year earlier.
Filing Explained
Microvast’s reported common-share count rose from 331,786 thousand at December 31, 2025 to 384,547 thousand at September 30, 2026, reducing existing holders’ percentage absent offsets.
In this Form 8-K, Microvast reports that after quarter-end it fully repaid and retired a
The company reports 384,547 thousand common shares outstanding as of
Installation and commissioning of the Huzhou Phase 3.2 production equipment is complete, but ramp-up depends on customer demand, production yields, product qualification, operating efficiency and working capital. The Clarksville pack assembly line is substantially complete; resumption of full-scale construction depends on additional financing or strategic partnerships.
8-K Event Classification
2 items: 2.02, 9.01
2 items
Item 2.02
Results of Operations and Financial Condition
Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Q3 revenue: $45.8 million
Q3 gross margin: 5.2%
Q3 net loss: $76.8 million
+5 more
8 metrics
Q3 revenue
$45.8 million
Quarter ended September 30, 2026
Q3 gross margin
5.2%
Quarter ended September 30, 2026
Q3 net loss
$76.8 million
Quarter ended September 30, 2026
Adjusted EBITDA (non-GAAP)
negative $60.8 million
Quarter ended September 30, 2026
Cash, cash equivalents and restricted cash
$124.4 million
As of September 30, 2026
Usable cash
Approximately $71.3 million
As of October 31, 2026
Total debt
$177.0 million
As of September 30, 2026
Net cash used in operating activities
$65.4 million
Nine months ended September 30, 2026
Key Terms
going concern, non-GAAP adjusted EBITDA, impairment loss of long-lived assets, working capital deficit
4 terms
going concern financial
"substantial doubt about our ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
non-GAAP adjusted EBITDA financial
"Non-GAAP adjusted EBITDA* of negative $60.8 million in Q3 2026"
Non-GAAP adjusted EBITDA is a measure of a company's profitability that shows earnings before interest, taxes, depreciation, and amortization, with certain adjustments made to exclude irregular or non-recurring expenses and income. It provides a clearer picture of ongoing operational performance by filtering out items that might distort the core business results. Investors use it to better compare how well different companies are performing without the noise of one-time events.
impairment loss of long-lived assets financial
"non-cash impairment charges of long-lived assets of $35.7 million"
working capital deficit financial
"we had a working capital deficit of $3.1 million"
A working capital deficit occurs when a company's short-term obligations—like bills, supplier payments and near-term debt—are larger than its readily available short-term resources such as cash, money expected from customers, and inventory that can be sold. Like a household whose monthly bills exceed its checking account, it signals potential difficulty paying immediate expenses, which matters to investors because it raises the chance the company will need outside financing or cut operations, affecting risk and value.
Earnings Snapshot
Revenue: $45.8 million
Q3 2026
Revenue
$45.8 million
Down 62.8% from $123.3 million in Q3 2025
Gross margin
5.2%
Compared with 37.6% in Q3 2025
Net loss
$76.8 million
Compared with $1.5 million in Q3 2025
Adjusted EBITDA (non-GAAP)
Negative $60.8 million
Compared with $21.9 million in Q3 2025
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was MVST's revenue in Q3 2026?
Revenue was $45.8 million, down 62.8% from $123.3 million in Q3 2025. The decrease was primarily driven by a 62.2% reduction in sales volume, from approximately 501.7 MWh to approximately 189.6 MWh.
Does Microvast expect enough cash to cover its obligations?
No. Based on current forecasts, Microvast expects available cash to be insufficient to meet obligations over the next 12 months absent additional financing, refinancing or extension of debt obligations, or significant further cost reductions. Management concluded its plans to alleviate substantial doubt could not be deemed probable of effective implementation, so the substantial doubt has not been alleviated.
What near-term debt maturities did Microvast report?
Microvast listed $41.7 million of convertible bonds due, with accrued interest, on or before January 31, 2027, plus $84.0 million of PRC-subsidiary short-term bank loans maturing at various dates over the next 12 months. It also listed principal installments on MPS long-term working-capital loans: $373,000 on December 19, 2026; $149,000 on March 18, 2027; $13.8 million on June 19, 2027; and $149,000 on September 18, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 9, 2026
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS. Employer Identification No.) | ||||||||||||
(Address of principal executive offices, including zip code)
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
The | ||||||||||||||
Item 2.02 Results of Operations and Financial Condition.
On November 9, 2026, Microvast Holdings, Inc. (the “Company”) issued a press release announcing its unaudited condensed consolidated financial results for the period ended September 30, 2026. In addition, the Company posted an accompanying slideshow presentation to its website summarizing its results for the same period. The full text of the press release is furnished as Exhibit 99.1 and the slideshow presentation is furnished as Exhibit 99.2 to this Current Report on Form 8-K. Exhibits 99.1 and 99.2 are hereby incorporated into this Item 2.02 by reference.
The information furnished in this Current Report on Form 8-K and Exhibits 99.1 and 99.2 attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 9, 2026 | MICROVAST HOLDINGS, INC. | |||||||
| By: | /s/ Rodney Worthen | |||||||
| Name: | Rodney Worthen | |||||||
| Title: | Chief Financial Officer | |||||||
Item 9.01 Financial Statements and Exhibits.
(d)Exhibits
Exhibit No. | Description | |||||||
| 99.1 | Press Release (Q3 2026) dated November 9, 2026 | |||||||
| 99.2 | Presentation (Q3 2026) dated November 9, 2026 | |||||||
2
Exhibit 99.1
Microvast Reports Third Quarter 2026 Financial Results
Houston, Texas, USA — Microvast Holdings, Inc. (NASDAQ:MVST) (“Microvast” or the “Company”), today announced its unaudited consolidated financial results for the quarter ended September 30, 2026 (“Q3 2026”).
“The third quarter presented a highly challenging operating environment as we navigated softer commercial vehicle demand across our key markets in Europe and APAC, compounded by ongoing industry pricing pressures,” said Yang Wu, Microvast’s Founder, Chairman, and Chief Executive Officer. The material decline in sales, gross margin and operating performance during the quarter have significantly constrained our liquidity. Considering our current balance sheet position, our focus is on the actions within our control: reducing costs, preserving liquidity, and negotiating with our lenders in an attempt to refinance, extend or restructure our near-term debt obligations. Regarding our current operations, installation and commissioning of our Huzhou Phase 3.2 production equipment have been completed and the pack assembly line at our Clarksville facility is substantially completed. We recognize that the outcome of these efforts is uncertain and depends on factors outside our control, including lender decisions and customer demand.”
Q3 2026 Results
•Revenues of $45.8 million, compared to $123.3 million in Q3 2025, decreasing by $77.5 million, or 62.8%. The decrease was primarily driven by a 62.2% reduction in sales volume from approximately 501.7 MWh in Q3 2025 to approximately 189.6 MWh in Q3 2026. The decline reflected weaker sales across Europe and APAC as the result of softer end-market demand for heavy-duty trucks, port equipment, and heavy mining equipment, which led to reduced orders from several of our long-standing customers across Europe and APAC. Demand continued to be adversely affected by evolving commercial vehicle regulatory and geopolitical dynamics, including the Indian and Korean markets, and demand shift towards lower cost products in India. The decrease in U.S. sales versus the prior year period was primarily due to our largest customer bringing product into 2025 as a result of uncertainty around tariff outcomes.
•Gross margin decreased to 5.2% from 37.6% in Q3 2025. This change was primarily attributable to a $9.3 million write-down for obsolete inventories related to specialized energy storage system (“ESS”) components and other inventories, which negatively impacted our gross margin by 20.4 percentage points. Excluding the impact of this non-cash charge, the decreased gross margin reflected the significant reduction in sales volume, and continued pricing pressure in the lithium battery industry. The decrease in revenue also reduced the absorption of fixed manufacturing and operating costs, further compressing gross margin.
•Operating expenses increased to $69.0 million, compared to $31.6 million in Q3 2025. This increase in operating expenses was primarily driven by non-cash impairment charges of long-lived assets of $35.7 million, including a $15.0 million, $4.4 million, and $16.3 million impairment loss for our operations in China, Germany, and the U.S., respectively. The impairment charges resulted from impairment testing of all production line assets and construction-in-progress assets, triggered by a material decline in sales, gross margin, and operating performance during Q3 2026.
•Net loss of $76.8 million, compared to net loss of $1.5 million in Q3 2025. The increase in net loss was primarily attributable to the $35.7 million non-cash impairment charges of long-lived
assets and lower gross profit on reduced revenue in the quarter. Non-GAAP adjusted net loss* was $76.0 million, compared to non-GAAP adjusted net profit* of $11.9 million in Q3 2025.
•Net loss per share of $0.20, compared to net loss per share of $0.00 in Q3 2025. Non-GAAP adjusted net loss per share* was $0.20, compared to non-GAAP adjusted net profit per share* of $0.04 in Q3 2025.
•Non-GAAP adjusted EBITDA* of negative $60.8 million in Q3 2026, compared to non-GAAP adjusted EBITDA* of $21.9 million in Q3 2025.
•Capital expenditures of $2.3 million, compared to $17.4 million in Q3 2025.
•Cash, cash equivalents and restricted cash of $124.4 million as of September 30, 2026, compared to $169.2 million as of December 31, 2025, and $142.6 million as of September 30, 2025.
Nine Months Ended September 30, 2026 Results (“YTD 2026”)
•Revenues of $193.7 million compared to $331.1 million in the nine months ended September 30, 2025 (“YTD 2025”), a decrease of 41.5%. The decrease was primarily driven by a 37.4% reduction in sales volume, which reflected weaker sales across Europe and APAC as the result of softer end-market demand for heavy-duty trucks, port equipment, and heavy mining equipment, which led to reduced orders from several of our long-standing customers, across Europe and APAC, and a $2.7 million IEEPA(1) tariff refund issued to a customer recorded as a reduction to our revenue in the current period.
•Gross margin decreased to 24.4% from 36.6% in YTD 2025. This change was primarily attributable to an $11.1 million write-down for obsolete inventories related to specialized ESS components and other inventories, which negatively impacted our gross margin by 5.7 percentage points. Excluding the impact of this non-cash charge, the decreased gross margin reflected the significant reduction in sales volume, changes in geographic markets, continued pricing pressure in the lithium battery industry, higher raw material prices, and lower production utilization, which reduced fixed cost absorption, slightly offset by the recognition of IEEPA(1) tariff refunds received.
•Operating expenses increased to $123.6 million, compared to $84.4 million in YTD 2025. This increase in operating expenses was primarily driven by non-cash impairment charges of long-lived assets of $35.8 million.
•Net loss of $40.6 million, compared to net loss of $45.8 million in YTD 2025. The decrease in net loss was primarily attributable to a $58.0 million non-cash gain from the change in fair value of the warrant liability prior to their expiration on July 23, 2026 and convertible loan prior to its settlement on May 28, 2026, compared to a $91.0 million non-cash loss in YTD 2025, partially offset by the $35.8 million non-cash impairment of long-lived assets, lower gross profit, a $15.4 million foreign exchange loss compared to a $9.0 million foreign exchange gain in YTD 2025, $5.4 million of income tax expense resulting from a full valuation allowance against our deferred tax assets. Non-GAAP adjusted net loss* was $96.0 million, compared to non-GAAP adjusted net profit* of $47.5 million in YTD 2025.
•Net loss per share of $0.11, compared to net loss per share of $0.14 in YTD 2025. Non-GAAP adjusted net loss per share* was $0.27, compared to non-GAAP adjusted net profit per share* of $0.15 in YTD 2025.
2
•Non-GAAP adjusted EBITDA* of negative $62.7 million in YTD 2026, compared to non-GAAP adjusted EBITDA* of $76.3 million in YTD 2025.
•Capital expenditures of $17.9 million, compared to $31.4 million in YTD 2025.
*The Company presents its financial results in accordance with generally accepted accounting principles in the United States of America (“GAAP”). However, management believes that using additional non-GAAP measures will enhance the evaluation of the profitability of the Company and its ongoing operations. Please see the tables on pages 14-17 below for reconciliations of GAAP to non-GAAP financial measures. The Consolidated Balance Sheets, Consolidated Statements of Operations, and Consolidated Statements of Cash Flows are derived from the consolidated financial statements presented in our Quarterly Report on Form 10-Q as of and for the three- and nine-month periods ended September 30, 2026.
(1)In February 2026, the United States Supreme Court ruled that certain tariffs imposed under the International Emergency Economic Powers Act (“IEEPA”) were not authorized by statute. Following the ruling, the U.S. Court of International Trade ordered U.S. Customs and Border Protection to suspend collection of such tariffs and to establish a process to refund amounts previously collected. As a result of this ruling, the Company is eligible to receive refunds of tariffs previously paid on qualifying imports. During the nine months ended September 30, 2026, the Company received $4.4 million in tariff refunds, excluding interest. Of this amount, $2.7 million was issued in tariff refunds to a customer. The IEEPA tariff refunds received were recognized as a reduction to the cost of revenue, while the refund issued to our customer was recognized as a reduction of revenue for the nine months ended September 30, 2026.
Liquidity and Balance Sheet
•Cash, cash equivalents and restricted cash totaled $124.4 million as of September 30, 2026, of which $84.8 million was comprised of cash and cash equivalents. Of the cash and cash equivalents, $30.4 million was held by our Chinese subsidiaries and $14.4 million was held by our European subsidiaries. Due to foreign regulatory restrictions, adverse tax consequences and localized working capital needs, we are currently unable to repatriate cash from China and Europe to fund our U.S. operations. We currently intend to retain available funds and any future earnings to satisfy our debt obligations and to support ongoing operations in China, Europe and the U.S.
•Net cash used in our operating activities was $65.4 million for the nine months ended September 30, 2026, compared to $59.5 million in cash generated by operating activities in the same period in 2025.
•Total debt was $177.0 million as of September 30, 2026, consisting of $135.3 million of bank borrowings and $41.7 million of convertible bonds issued by Microvast Power Systems Co., Ltd. (“MPS”), our principal operating subsidiary in China, to Huzhou Saiyuan. Current bank borrowings, notes payable and current bonds payable totaled approximately $196.0 million, and we had a working capital deficit of $3.1 million.
•As of the date of this release, our near-term debt obligations include: (i) $41.7 million of convertible bonds, due, together with accrued interest, on or before January 31, 2027; (ii) $84.0 million of short-term bank loans of our PRC subsidiaries, which mature at various dates during the next twelve months; and (iii) $373 thousand, $149 thousand, $13.8 million and $149 thousand of principal under MPS’s long-term working capital loans, due December 19, 2026, March 18, 2027, June 19, 2027 and September 18, 2027, respectively. Our ability to
3
make these payments depends on our ability to refinance or extend these obligations. We are in ongoing negotiations with our lenders regarding these obligations, but there can be no assurance that these obligations will be refinanced or extended on acceptable terms, or at all. A failure to make any of these payments will result in an event of default and the acceleration of substantially all of our bank borrowings and bonds payable and the enforcement of security over MPS’s assets and our equity interest in MPS. As of September 30, 2026, we also had outstanding borrowings of $22.4 million under our loan facilities agreement entered into on September 27, 2022 with a group of lenders led by a bank in China, which were due on December 10, 2026. Subsequent to September 30, 2026, we repaid the remaining balance of $22.4 million, and that facility was fully repaid and retired. Additionally, during the nine months ended September 30, 2026, we secured $95.8 million of bank borrowings, of which $59.8 million represented refinanced debt, and since September 30, 2026, we have refinanced an additional $8.9 million of short-term bank borrowings.
•As of October 31, 2026, our total usable cash across all of our entities was approximately $71.3 million. Based on our current forecasts, absent additional financing, the refinancing or extension of our debt obligations, or further cost reductions, we expect our available cash to be insufficient to meet our obligations as they come due over the next twelve months, including our near-term debt maturities and pending legal settlements.
•Our revenues are materially concentrated with a small number of customers, and there is significant uncertainty regarding the level of future orders from certain of our largest customers. One of our significant European customers was recently acquired by a third party, which creates additional uncertainty regarding its future purchases from us. We currently have limited visibility into our revenue for the next several quarters and into cash collections in the near term, and our first quarter has historically reflected nominal reductions in activity related to the Chinese New Year holiday.
Going Concern
Based on our current cash flow forecasts, absent additional financing, the refinancing, extension or restructuring of our debt obligations, or significant further reductions in costs, we expect our available cash to be insufficient to meet our obligations as they come due over the next twelve months. Management has concluded that its plans to alleviate the substantial doubt about our ability to continue as a going concern cannot be deemed probable of being effectively implemented and, accordingly, the substantial doubt has not been alleviated.
2026 Outlook
In light of the uncertainty regarding our liquidity position, our ongoing discussions with our lenders regarding the refinancing, extension or restructuring of our near-term debt obligations, and softer end-market demand, we are implementing operating cost reduction initiatives across all areas of the business, reducing or deferring certain discretionary capital expenditures and implementing targeted reductions in workforce in certain of our operations. Our cost-reduction program has not been fully implemented, and the cash costs associated with these actions have strained and may continue to strain our near-term liquidity.
•We continue to explore potential opportunities in the commercial vehicle market.
•Installation and commissioning of the Phase 3.2 production equipment at our Huzhou, China facility have been completed. Production ramp-up is dependent on customer demand,
4
production yields, product qualification, operating efficiency and working capital availability. Unless production volumes increase sufficiently, the Phase 3.2 line will operate below its designed capacity.
•The pack assembly line at our Clarksville facility is substantially completed. Resumption of full-scale construction at the facility remains contingent upon securing additional financing or strategic partnerships.
Webcast Information
Company management will host a conference call and webcast on November 9, 2026, at 4:00 p.m. Central Time, to discuss the Company's financial results. The live webcast and accompanying slide presentation will be accessible from the Events & Presentations section of Microvast’s investor relations website (https://ir.microvast.com/events-presentations/events). A replay will be available following the conclusion of the event.
About Microvast
Microvast strives to be a global leader in advanced battery technologies, with a portfolio of more than 890 patents. Founded in Texas in 2006 and headquartered in Houston, the company has spent two decades engineering cutting-edge battery systems that are intended to power a cleaner future.
For more information, please visit www.microvast.com or follow us on LinkedIn (@microvast).
Contact:
Investor Relations
ir@microvast.com
Cautionary Statement Regarding Forward-Looking Statements
This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on assumptions with respect to the future and management's current expectations, involve certain risks and uncertainties and are not guarantees. These forward-looking statements include, but are not limited to, our ability to alleviate the substantial doubt regarding our ability to continue as a going concern, our ability to implement our plans to alleviate that substantial doubt, our ability to meet our current and near-term debt and liquidity requirements, our future results of operations and financial position and liquidity, our operational performance, our strategy, our exploration of potential refinancings or extensions of our debt obligations, including potential results thereof, our ability to regain compliance with and maintain the listing of our common stock on the Nasdaq stock exchange, the potential development and commercialization of Microvast's KAF™ (“Kids Are Future”) electric powertrain platform, the projected costs, prospects, plans and objectives of management for continued operations, including regarding demand for our products and introduction of new products, the adoption of such offerings by customers, our expectations relating to backlog, current expectations relating to legal proceedings as well as potential impacts from any proposed or recently enacted legislation, including impacts from the newly-effective consumption tax on lithium products and forthcoming elimination of certain battery products export value-added tax rebates in China. In some cases, you may also identify forward-looking statements by words such as “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “objective,” “plan,” “project,” “predict,” “outlook,” “should,” “will,” “would,” or the negative of these terms, or other comparable terminology intended to identify
5
statements about the future. Such forward-looking statements are based upon the current beliefs and expectations of management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results or outcomes, or the timing of results or outcomes, may differ materially from the results anticipated in these forward-looking statements. We do not assume any obligation to update any forward-looking statements.
In addition to factors identified elsewhere in this communication, the following factors, among others, could cause actual results and the timing of events to differ materially from the anticipated results or other expectations expressed in the forward-looking statements: (1) the risk that our plans intended to alleviate substantial doubt about our ability to continue as a going concern will not be effectively implemented within one year after the date our financial statements are issued or, when implemented, will not mitigate the conditions and events that raise substantial doubt; (2) the risk that we will not be able to timely service and pay off our existing debt obligations and otherwise satisfy our liquidity requirements, including our short-term bank borrowings and bonds payable prior to their maturity, as well as to successfully negotiate with our lenders to refinance, restructure or extend existing debt or incur additional debt on terms and at rates acceptable to us; (3) the risk that MPS, our principal operating subsidiary in China, becomes insolvent, and the effect of any such insolvency on our business, financial condition and results of operations; (4) risks that we will continue to experience difficulties in generating and maintaining demand for our products, leading to a continued decline in our revenue, financial condition and results of operations; (5) risks regarding our dependency on a small number of customers, the loss of any additional significant customers and any additional reductions in pricing or volume, deferrals or cancellations of existing or future orders from our current customers; (6) risks related to our ability to attract new customers and retain existing customers; (7) risks that we will not be able to collect overdue accounts receivable; (8) risks related to the effects of existing and future litigation and how such litigation has affected and will continue to affect our cash position; (9) risk of additional product liability or regulatory lawsuits or proceedings relating to our products or services; (10) risks related to restrictions in our existing and any future credit facilities, our ability to comply with financial covenants and the risk of cross-default, the risk that waivers or amendments may not be obtained from our lenders, the risk that our indebtedness may be accelerated or classified as current, and the risk of any defaults diluting ownership in our subsidiaries; (11) risks related to the impact of our indebtedness, debt service obligations and debt covenants, and how they have affected and will continue to affect our cash position; (12) risks related to the effect of the substantial doubt about our ability to continue as a going concern on our relationship with customers and suppliers, our ability to maintain labor relations and attract and retain qualified key full-time and contract personnel, and our ability to raise capital; (13) risks related to fluctuations in availability and continued increases in the price of raw materials; (14) the risk that tariffs imposed on products of the PRC into the United States will continue to increase costs and impact our business, that pursuing refunds of such tariffs may not be successful and the risk that pursuit of such refunds may divert the time and attention of management; (15) risks regarding our ability to regain and maintain compliance with Nasdaq listing requirements, that our common stock may be delisted and there will no longer be a market for our common stock, and that stockholders may lose some or all of their investment in our common stock; (16) risks related to difficulties in controlling manufacturing costs, maintaining manufacturing capacity and establishing manufacturing capacity in the future, and the risk of issues, delays, disruptions or quality control problems; (17) the risk that the unavailability, reduction or elimination of, or uncertainty regarding, government and economic incentives or subsidies available to us, end-users or OEMs will continue to have a material adverse effect on our business, financial condition and results of operations; (18) risks of operations in the People’s Republic of China (“PRC” or “China”); (19) risks related to potential changes in general economic conditions, including increases in interest rates and associated Federal Reserve policies, a potential economic recession, and the impact of inflation on our business; (20) risks related to our ability to compete in the highly competitive market in which we compete, including with respect to our competitive landscape, technology evolution or regulatory changes; (21) risks related to supplier
6
concentration and constrained supplier capacity, that our limited suppliers may fail to deliver components according to schedules, prices, quality and volumes that are acceptable to us, the risk that we may be unable to manage these components effectively and the risks related to our status as a relatively low-volume purchaser; (22) risk that we are unable to secure or protect our intellectual property; (23) risk that our customers or third-party suppliers are unable to meet their obligations fully or in a timely manner; (24) risks related to our lengthy sales cycle for our products; (25) risks related to our ability to maintain and enhance our reputation and brand recognition; (26) risks relating to facing strong competition for our products and services from a growing list of established and new competitors; (27) risks related to the effectiveness of our information technology and operational technology systems and practices to detect and defend against evolving cyberattacks; (28) risks related to changing laws regarding cybersecurity and data privacy, and any cybersecurity threat or event; (29) risks related to the effects and associated cost of compliance with existing and future laws and governmental regulations; (30) risks relating to whether renewable energy technologies are suitable for widespread adoption or if sufficient demand for our offerings does not develop or takes longer to develop than we anticipate; (31) risks of economic, financial and other impacts of a material global event such as a pandemic, including global supply chain disruptions; (32) risks to our business caused by the impacts of geopolitical events, such as the ongoing conflicts in the Middle East, including hostilities with Iran, the war between Russia and Ukraine, and other current or future conflicts; and (33) risks associated with maintaining our international operations, including unfavorable and uncertain regulatory, political, economic, tax, and labor conditions. Microvast’s annual, quarterly and other filings with the U.S. Securities and Exchange Commission (the “SEC”) identify, address and discuss these and other factors in the sections entitled “Risk Factors.”
The foregoing list of factors is not exhaustive and new factors may emerge from time to time that could also affect actual performance and results. For more information, please see the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025 and in Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2026.
Actual results, performance or achievements may differ materially, and potentially adversely, from any forward-looking statements and the assumptions on which those forward-looking statements are based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as forward-looking statements are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond our control.
All information set forth herein speaks only as of the date hereof, and we disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date hereof except as may be required under applicable securities laws. Forecasts and estimates regarding our industry and end markets are based on sources we believe to be reliable, however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.
All references to the “Company,” “we,” “us,” or “our” refer to Microvast Holdings, Inc. and its consolidated subsidiaries.
Non-GAAP Financial Measures
To provide investors with additional information regarding our financial results, Microvast has disclosed in this earnings release non-GAAP financial measures, including non-GAAP adjusted gross profit, non-GAAP EBITDA, non-GAAP adjusted EBITDA, non-GAAP adjusted operating expenses, non-GAAP adjusted net profit/(loss), non-GAAP adjusted net profit/(loss) per share, and non-GAAP adjusted gross margin which are non-GAAP financial measures as defined under the rules of the
7
SEC. These are intended as supplemental measures of our financial performance that are not required by, or presented in accordance with GAAP.
Reconciliations to the most comparable GAAP measures, gross profit, gross margin, operating expenses, net profit/(loss), and net profit/(loss) per share, are contained in tabular form in the unaudited financial statements below. Non-GAAP adjusted gross profit is GAAP gross profit as adjusted for non-cash share-based compensation expense included in cost of revenues. Non-GAAP adjusted net profit/(loss) is GAAP net profit/(loss) as adjusted for non-cash share-based compensation expense and change in valuation of warrant liability and convertible loan. Non-GAAP adjusted net profit/(loss) per common share is GAAP net profit/(loss) per common share as adjusted for non-cash share-based compensation expense and change in valuation of warrant liability and convertible loan per common share. Non-GAAP EBITDA is defined as net profit/(loss) excluding depreciation and amortization, interest expense, interest income, and income tax expense or benefit. Non-GAAP adjusted EBITDA is defined as net profit/(loss) excluding depreciation and amortization, non-cash settled share-based compensation expense, interest expense, interest income, changes in fair value of our warrant liability and convertible loan and income tax expense or benefit. Non-GAAP adjusted operating expenses is defined as operating expenses excluding non-cash share-based compensation expense. Non-GAAP adjusted gross margin is defined as GAAP gross margin as adjusted for non-cash share-based compensation expense included in cost of revenues.
We use non-GAAP adjusted gross profit, non-GAAP EBITDA, non-GAAP adjusted EBITDA, non-GAAP adjusted operating expenses, non-GAAP adjusted net profit/(loss), non-GAAP adjusted net profit/(loss) per share and non-GAAP adjusted gross margin for financial and operational decision-making and as a means to evaluate period-to-period comparisons. We consider them to be important measures because they help illustrate underlying trends in our business and our historical operating performance on a more consistent basis. We believe that these non-GAAP financial measures, when taken together with their most directly comparable GAAP measures provide meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our recurring core business operating results.
We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting, and analyzing future periods. These non-GAAP financial measures also facilitate management’s internal comparisons to our historical performance. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making and (2) they are used by our institutional investors and the analyst community to help them analyze the health of our business. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management team and board of directors.
Non-GAAP financial measures have limitations as an analytical tool, and you should not consider them in isolation, or as a substitute for, financial information prepared in accordance with GAAP. For example, our calculation of non-GAAP adjusted EBITDA may differ from similarly titled non-GAAP measures, if any, reported by our peer companies, or our peer companies may use other measures to calculate their financial performance, and therefore our use of non-GAAP adjusted EBITDA may not be directly comparable to similarly titled measures of other companies. The principal limitation of non-GAAP adjusted EBITDA is that it excludes significant expenses and income that are required by GAAP to be recorded in our financial statements. In addition, it is subject to inherent limitations as it reflects the exercise of judgments by management about which expense and income are excluded or included in determining this non-GAAP financial measure. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. In addition, such financial information is unaudited and does not conform to SEC Regulation S-X and as
8
a result, such information may be presented differently in our future filings with the SEC. Changes in the fair value of our warrant liability and convertible loan, which are excluded from non-GAAP adjusted EBITDA and non-GAAP adjusted net profit/(loss), are not expected to recur in future periods, because the public and private warrants issued in connection with the July 23, 2021 business combination with Tuscan Holdings Corp. expired unexercised on July 23, 2026 and the convertible loan was converted and settled on May 28, 2026.
9
MICROVAST HOLDINGS, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data, unaudited)
| September 30, 2026 | December 31, 2025 | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 84,833 | $ | 104,963 | |||||||
| Restricted cash | 39,611 | 64,275 | |||||||||
Accounts receivable (net of allowance for credit losses of $3,087 and $4,693 as of September 30, 2026 and December 31, 2025, respectively) | 103,064 | 155,763 | |||||||||
| Notes receivable | 1,051 | 5,590 | |||||||||
| Inventories, net | 95,043 | 89,411 | |||||||||
| Prepaid expenses and other current assets | 29,111 | 17,221 | |||||||||
| Assets held for sale | — | 11,500 | |||||||||
| Total Current Assets | 352,713 | 448,723 | |||||||||
| Property, plant and equipment, net | 497,050 | 508,057 | |||||||||
| Land use rights, net | 11,834 | 11,570 | |||||||||
| Acquired intangible assets, net | 1,864 | 2,183 | |||||||||
| Operating lease right-of-use assets | 16,861 | 17,336 | |||||||||
| Deferred tax assets | — | 5,429 | |||||||||
| Other non-current assets | 12,597 | 12,150 | |||||||||
| Total Assets | $ | 892,919 | $ | 1,005,448 | |||||||
| Liabilities | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 48,473 | $ | 47,003 | |||||||
| Notes payable | 33,470 | 78,321 | |||||||||
| Advance from customers | 4,492 | 5,605 | |||||||||
| Accrued expenses and other current liabilities | 106,712 | 123,429 | |||||||||
| Amounts due to related parties | 212 | 2 | |||||||||
| Convertible loan measured at fair value | — | 140,929 | |||||||||
| Short-term bank borrowings | 120,794 | 93,052 | |||||||||
| Bonds payable | 41,693 | — | |||||||||
| Total Current Liabilities | 355,846 | 488,341 | |||||||||
| Long-term bonds payable | — | 41,693 | |||||||||
| Long-term bank borrowings | 14,468 | 13,227 | |||||||||
| Operating lease liabilities | 13,475 | 14,476 | |||||||||
| Other non-current liabilities | 36,290 | 37,198 | |||||||||
| Total Liabilities | $ | 420,079 | $ | 594,935 | |||||||
| Stockholders’ Equity | |||||||||||
| Common Stock ($0.0001 par value, 750,000 shares authorized; 386,235 and 333,474 shares issued, and 384,547 and 331,786 shares outstanding as of September 30, 2026 and December 31, 2025) | $ | 39 | $ | 34 | |||||||
| Preferred Stock ($0.0001 par value, 50,000 shares authorized; none issued and outstanding as of September 30, 2026 and December 31, 2025) | — | — | |||||||||
| Additional paid-in capital | 1,627,962 | 1,543,797 | |||||||||
| Statutory reserves | 6,032 | 6,032 | |||||||||
| Accumulated deficit | (1,162,753) | (1,122,176) | |||||||||
| Accumulated other comprehensive loss | 1,560 | (17,174) | |||||||||
| Total Equity | $ | 472,840 | $ | 410,513 | |||||||
| Total Liabilities and Equity | $ | 892,919 | $ | 1,005,448 | |||||||
10
MICROVAST HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Revenues | $ | 45,805 | $ | 123,287 | $ | 193,679 | $ | 331,117 | |||||||||||||||
| Cost of revenues | (34,092) | (72,151) | (135,311) | (205,242) | |||||||||||||||||||
| Write-down for obsolete inventories | (9,346) | (4,724) | (11,067) | (4,724) | |||||||||||||||||||
| Gross profit | 2,367 | 46,412 | 47,301 | 121,151 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| General and administrative expenses | (20,371) | (17,760) | (47,198) | (43,064) | |||||||||||||||||||
| Research and development expenses | (8,362) | (7,757) | (26,032) | (23,724) | |||||||||||||||||||
| Selling and marketing expenses | (4,569) | (6,006) | (14,654) | (16,229) | |||||||||||||||||||
| Impairment loss of long-lived assets | (35,741) | (36) | (35,765) | (1,400) | |||||||||||||||||||
| Total operating expenses | (69,043) | (31,559) | (123,649) | (84,417) | |||||||||||||||||||
| Subsidy income | 9 | 44 | 27 | 2,455 | |||||||||||||||||||
| (Loss) profit from operations | (66,667) | 14,897 | (76,321) | 39,189 | |||||||||||||||||||
| Other income and expenses: | |||||||||||||||||||||||
| Interest income | 364 | 236 | 1,479 | 611 | |||||||||||||||||||
| Interest expense | (1,358) | (1,255) | (3,913) | (3,695) | |||||||||||||||||||
| Changes in fair value of warrant liability and convertible loan | — | (12,641) | 58,001 | (91,002) | |||||||||||||||||||
| Foreign exchange (loss) gain | (3,772) | (1,903) | (15,377) | 8,951 | |||||||||||||||||||
| Other income (expense), net | 62 | (84) | 983 | 1,148 | |||||||||||||||||||
| Loss before provision for income taxes | (71,371) | (750) | (35,148) | (44,798) | |||||||||||||||||||
| Income tax expense | (5,429) | (739) | (5,429) | (959) | |||||||||||||||||||
| Net loss | $ | (76,800) | $ | (1,489) | $ | (40,577) | $ | (45,757) | |||||||||||||||
| Net loss per share - Basic and diluted | $ | (0.20) | $ | — | $ | (0.11) | $ | (0.14) | |||||||||||||||
| Weighted average shares outstanding - Basic and diluted | 384,537 | 323,756 | 355,649 | 323,611 | |||||||||||||||||||
11
MICROVAST HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
| Nine Months Ended September 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| Cash flows from operating activities | |||||||||||
| Net loss | $ | (40,577) | $ | (45,757) | |||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||
| Depreciation of property, plant and equipment | 24,775 | 24,169 | |||||||||
| Noncash lease expenses | 2,067 | 1,962 | |||||||||
| Share-based compensation | 2,614 | 2,277 | |||||||||
| Changes in fair value of warrant liability and convertible loan | (58,001) | 91,002 | |||||||||
| (Reversal) provision of credit losses | (813) | 1,844 | |||||||||
| Impairment loss of long-lived assets | 35,765 | 1,400 | |||||||||
| Product warranty | 7,786 | 13,376 | |||||||||
| Deferred income taxes | 5,429 | — | |||||||||
| Write-down for obsolete inventories | 11,067 | 4,724 | |||||||||
| Other, net | (50) | 198 | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Notes receivable | (3,722) | (18,270) | |||||||||
| Accounts receivable | 56,042 | (22,960) | |||||||||
| Inventories | (18,165) | 17,382 | |||||||||
| Prepaid expenses and other current assets | (12,029) | 7,568 | |||||||||
| Amounts due from/to related parties | 207 | (5) | |||||||||
| Other non-current assets | 2,750 | 1,070 | |||||||||
| Notes payable | (46,877) | 4,225 | |||||||||
| Accounts payable | (623) | (6,813) | |||||||||
| Advance from customers | (1,347) | (38,176) | |||||||||
| Accrued expenses and other liabilities | (27,692) | 20,645 | |||||||||
| Operating lease liabilities | (1,966) | (2,158) | |||||||||
| Other non-current liabilities | (2,081) | 1,783 | |||||||||
| Net cash (used in) generated from operating activities | (65,441) | 59,486 | |||||||||
| Cash flows from investing activities | |||||||||||
| Purchases of property, plant and equipment | (16,502) | (19,191) | |||||||||
| Proceeds on disposal of property, plant and equipment | 10,865 | 3,736 | |||||||||
| Net cash used in investing activities | (5,637) | (15,455) | |||||||||
| Cash flows from financing activities | |||||||||||
| Proceeds from bank borrowings | 95,763 | 70,050 | |||||||||
| Repayment of bank borrowings | (72,104) | (65,965) | |||||||||
| Repayment of bonds payable | — | (1,375) | |||||||||
| Proceeds from sale of common stocks | 1,350 | — | |||||||||
| Payment for equity issuance costs | (329) | — | |||||||||
| Deferred payment related to purchases of property, plant and equipment | (1,368) | (12,254) | |||||||||
| Net cash generated from (used in) financing activities | 23,312 | (9,544) | |||||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 2,972 | (1,461) | |||||||||
| (Decrease) increase in cash, cash equivalents and restricted cash | (44,794) | 33,026 | |||||||||
| Cash, cash equivalents and restricted cash at beginning of the period | 169,238 | 109,601 | |||||||||
| Cash, cash equivalents and restricted cash at end of the period | $ | 124,444 | $ | 142,627 | |||||||
12
MICROVAST HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
| Nine Months Ended September 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| Reconciliation to amounts on consolidated balance sheets | |||||||||||
| Cash and cash equivalents | $ | 84,833 | $ | 90,748 | |||||||
| Restricted cash | 39,611 | 51,879 | |||||||||
| Total cash, cash equivalents and restricted cash | $ | 124,444 | $ | 142,627 | |||||||
13
MICROVAST HOLDINGS, INC.
RECONCILIATION OF GROSS PROFIT TO ADJUSTED GROSS PROFIT
(In thousands, except percentages, unaudited)
RECONCILIATION OF GROSS PROFIT TO ADJUSTED GROSS PROFIT
(In thousands, except percentages, unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Revenues | $ | 45,805 | $ | 123,287 | $ | 193,679 | $ | 331,117 | |||||||||||||||
| Cost of revenues | (34,092) | (72,151) | (135,311) | (205,242) | |||||||||||||||||||
| Write-down for obsolete inventories | (9,346) | (4,724) | (11,067) | (4,724) | |||||||||||||||||||
| Gross profit (GAAP) | $ | 2,367 | $ | 46,412 | $ | 47,301 | $ | 121,151 | |||||||||||||||
| Gross margin | 5.2 | % | 37.6 | % | 24.4 | % | 36.6 | % | |||||||||||||||
| Non-cash settled share-based compensation (included in cost of revenues) | 29 | 60 | 101 | 184 | |||||||||||||||||||
| Adjusted gross profit (non-GAAP) | $ | 2,396 | $ | 46,472 | $ | 47,402 | $ | 121,335 | |||||||||||||||
| Adjusted gross margin (non-GAAP) | 5.2 | % | 37.7 | % | 24.5 | % | 36.6 | % | |||||||||||||||
14
MICROVAST HOLDINGS, INC.
RECONCILIATION OF OPERATING EXPENSES TO ADJUSTED OPERATING EXPENSES
(In thousands, unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| General and administrative expenses | $ | (20,371) | $ | (17,760) | $ | (47,198) | $ | (43,064) | |||||||||||||||
| Research and development expenses | (8,362) | (7,757) | (26,032) | (23,724) | |||||||||||||||||||
| Selling and marketing expenses | (4,569) | (6,006) | (14,654) | (16,229) | |||||||||||||||||||
| Impairment loss of long-lived assets | (35,741) | (36) | (35,765) | (1,400) | |||||||||||||||||||
| Operating expenses (GAAP) | $ | (69,043) | $ | (31,559) | $ | (123,649) | $ | (84,417) | |||||||||||||||
| Non-cash settled share-based compensation (included in operating expenses) | 735 | 668 | 2,513 | 2,093 | |||||||||||||||||||
| Adjusted operating expenses (non-GAAP) | $ | (68,308) | $ | (30,891) | $ | (121,136) | $ | (82,324) | |||||||||||||||
15
MICROVAST HOLDINGS, INC.
RECONCILIATION OF NET LOSS TO ADJUSTED NET (LOSS) PROFIT
(In thousands, except per share data, unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Net loss (GAAP) | $ | (76,800) | $ | (1,489) | $ | (40,577) | $ | (45,757) | |||||||||||||||
Changes in fair value of warrant liability and convertible loan* | — | 12,641 | (58,001) | 91,002 | |||||||||||||||||||
| Non-cash settled share-based compensation* | 764 | 728 | 2,614 | 2,277 | |||||||||||||||||||
| Adjusted net (loss) profit (non-GAAP) | $ | (76,036) | $ | 11,880 | $ | (95,964) | $ | 47,522 | |||||||||||||||
*The tax effect of the adjustments was nil.
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Net loss per common share-Basic (GAAP) | $ | (0.20) | $ | — | $ | (0.11) | $ | (0.14) | |||||||||||||||
| Changes in fair value of warrant liability and convertible loan per common share | — | 0.04 | (0.17) | 0.28 | |||||||||||||||||||
| Non-cash settled share-based compensation per common share | — | — | 0.01 | 0.01 | |||||||||||||||||||
| Adjusted net (loss) profit per common share-Basic (non-GAAP) | $ | (0.20) | $ | 0.04 | $ | (0.27) | $ | 0.15 | |||||||||||||||
16
MICROVAST HOLDINGS, INC.
RECONCILIATION OF NET LOSS TO EBITDA AND ADJUSTED EBITDA
(In thousands, unaudited)
RECONCILIATION OF NET LOSS TO EBITDA AND ADJUSTED EBITDA
(In thousands, unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Net loss (GAAP) | $ | (76,800) | $ | (1,489) | $ | (40,577) | $ | (45,757) | |||||||||||||||
| Interest expense (income), net | 994 | 1,019 | 2,434 | 3,084 | |||||||||||||||||||
| Income tax expense | 5,429 | 739 | 5,429 | 959 | |||||||||||||||||||
| Depreciation and amortization | 8,815 | 8,272 | 25,374 | 24,747 | |||||||||||||||||||
| EBITDA (non-GAAP) | $ | (61,562) | $ | 8,541 | $ | (7,340) | $ | (16,967) | |||||||||||||||
| Changes in fair value of warrant liability and convertible loan | — | 12,641 | (58,001) | 91,002 | |||||||||||||||||||
| Non-cash settled share-based compensation | 764 | 728 | 2,614 | 2,277 | |||||||||||||||||||
| Adjusted EBITDA (non-GAAP) | $ | (60,798) | $ | 21,910 | $ | (62,727) | $ | 76,312 | |||||||||||||||
17
Q 3 2 0 2 6
2 Disclaimer Forward-Looking Statements This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on assumptions with respect to the future and management’s current expectations, involve certain risks and uncertainties and are not guarantees. These forward-looking statements include, but are not limited to, our ability to alleviate the substantial doubt regarding our ability to continue as a going concern, our ability to implement our plans to alleviate that substantial doubt, our ability to meet our current and near-term debt and liquidity requirements, our future results of operations and financial position and liquidity, our operational performance, our strategy, our exploration of potential refinancings or extensions of our debt obligations, including potential results thereof, our ability to regain compliance with and maintain the listing of our common stock on the Nasdaq stock exchange, the potential development and commercialization of Microvast’s KAF (“Kids Are Future”) electric powertrain platform, the projected costs, prospects, plans and objectives of management for continued operations, including regarding demand for our products and introduction of new products, the adoption of such offerings by customers, our expectations relating to backlog, current expectations relating to legal proceedings as well as potential impacts from any proposed or recently enacted legislation, including impacts from the newly-effective consumption tax on lithium products and forthcoming elimination of certain battery products export value-added tax rebates in China. In some cases, you may also identify forward-looking statements by words such as “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “objective,” “plan,” “project,” “predict,” “outlook,” “should,” “will,” “would,” or the negative of these terms, or other comparable terminology intended to identify statements about the future. Such forward-looking statements are based upon the current beliefs and expectations of management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results or outcomes, or the timing of results or outcomes, may differ materially from the results anticipated in these forward-looking statements. We do not assume any obligation to update any forward-looking statements. In addition to factors identified elsewhere in this presentation, the following factors, among others, could cause actual results and the timing of events to differ materially from the anticipated results or other expectations expressed in the forward-looking statements: (1) the risk that our plans intended to alleviate substantial doubt about our ability to continue as a going concern will not be effectively implemented within one year after the date our financial statements are issued or, when implemented, will not mitigate the conditions and events that raise substantial doubt; (2) the risk that we will not be able to timely service and pay off our existing debt obligations and otherwise satisfy our liquidity requirements, including our short-term bank borrowings and bonds payable prior to their maturity, as well as to successfully negotiate with our lenders to refinance, restructure or extend existing debt or incur additional debt on terms and at rates acceptable to us; (3) the risk that MPS, our principal operating subsidiary in China, becomes insolvent, and the effect of any such insolvency on our business, financial condition and results of operations; (4) risks that we will continue to experience difficulties in generating and maintaining demand for our products, leading to a continued decline in our revenue, financial condition and results of operations; (5) risks regarding our dependency on a small number of customers, the loss of any additional significant customers and any additional reductions in pricing or volume, deferrals or cancellations of existing or future orders from our current customers; (6) risks related to our ability to attract new customers and retain existing customers; (7) risks that we will not be able to collect overdue accounts receivable; (8) risks related to the effects of existing and future litigation and how such litigation has affected and will continue to affect our cash position; (9) risk of additional product liability or regulatory lawsuits or proceedings relating to our products or services; (10) risks related to restrictions in our existing and any future credit facilities, our ability to comply with financial covenants and the risk of cross-default, the risk that waivers or amendments may not be obtained from our lenders, the risk that our indebtedness may be accelerated or classified as current, and the risk of any defaults diluting ownership in our subsidiaries; (11) risks related to the impact of our indebtedness, debt service obligations and debt covenants, and how they have affected and will continue to affect our cash position; (12) risks related to the effect of the substantial doubt about our ability to continue as a going concern on our relationship with customers and suppliers, our ability to maintain labor relations and attract and retain qualified key full-time and contract personnel, and our ability to raise capital; (13) risks related to fluctuations in availability and continued increases in the price of raw materials; (14) the risk that tariffs imposed on products of the PRC into the United States will continue to increase costs and impact our business, that pursuing refunds of such tariffs may not be successful and the risk that pursuit of such refunds may divert the time and attention of management; (15) risks regarding our ability to regain and maintain compliance with Nasdaq listing requirements, that our common stock may be delisted and there will no longer be a market for our common stock, and that stockholders may lose some or all of their investment in our common stock; (16) risks related to difficulties in controlling manufacturing costs, maintaining manufacturing capacity and establishing manufacturing capacity in the future, and the risk of issues, delays, disruptions or quality control problems; (17) the risk that the unavailability, reduction or elimination of, or uncertainty regarding, government and economic incentives or subsidies available to us, end-users or OEMs will continue to have a material adverse effect on our business, financial condition and results of operations; (18) risks of operations in the People’s Republic of China (“PRC” or “China”); (19) risks related to potential changes in general economic conditions, including increases in interest rates and associated Federal Reserve policies, a potential economic recession, and the impact of inflation on our business; (20) risks related to our ability to compete in the highly competitive market in which we compete, including with respect to our competitive landscape, technology evolution or regulatory changes; Non-GAAP Financial Measures This presentation contains EBITDA, adjusted EBITDA, and adjusted net profit/loss, which are non-GAAP financial measures. EBITDA is defined as net profit/(loss) excluding depreciation and amortization, interest expense, interest income, and income tax expense or benefit. Non-GAAP adjusted EBITDA is defined as net profit/loss excluding depreciation and amortization, non-cash settled share-based compensation (“SBC”) expense, interest expense, interest income, changes in fair value of our warrant and convertible loan and income tax expense or benefit. Adjusted net profit/loss is GAAP net profit/loss as adjusted for non-cash stock-based compensation expense and changes to the valuation of warrant liabilities and convertible loan. In addition to Microvast's results determined in accordance with GAAP, Microvast's management uses these non-GAAP financial metrics to evaluate the company’s ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP financial information, when taken collectively, may be helpful to investors in assessing Microvast's operating performance. We believe that the use of these non-GAAP metrics provides an additional tool for investors to use in evaluating ongoing operating results and trends because it eliminates the effect of financing, non-recurring items, capital expenditures, and non-cash expenses. In addition, our presentation of EBITDA, adjusted EBITDA, and adjusted net profit/loss should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. Our computation of non-GAAP financial metrics may not be comparable to other similarly titled measures computed by other companies because not all companies calculate these measures in the same fashion. Because of these limitations, these non-GAAP financial metrics should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP. We compensate for these limitations by relying primarily on our GAAP results and using non-GAAP financial metrics on a supplemental basis. Investors should review the reconciliations in this presentation and not rely on any single financial measure to evaluate our business. (21) risks related to supplier concentration and constrained supplier capacity, that our limited suppliers may fail to deliver components according to schedules, prices, quality and volumes that are acceptable to us, the risk that we may be unable to manage these components effectively and the risks related to our status as a relatively low-volume purchaser; (22) risk that we are unable to secure or protect our intellectual property; (23) risk that our customers or third-party suppliers are unable to meet their obligations fully or in a timely manner; (24) risks related to our lengthy sales cycle for our products; (25) risks related to our ability to maintain and enhance our reputation and brand recognition; (26) risks relating to facing strong competition for our products and services from a growing list of established and new competitors; (27) risks related to the effectiveness of our information technology and operational technology systems and practices to detect and defend against evolving cyberattacks; (28) risks related to changing laws regarding cybersecurity and data privacy, and any cybersecurity threat or event; (29) risks related to the effects and associated cost of compliance with existing and future laws and governmental regulations; (30) risks relating to whether renewable energy technologies are suitable for widespread adoption or if sufficient demand for our offerings does not develop or takes longer to develop than we anticipate; (31) risks of economic, financial and other impacts of a material global event such as a pandemic, including global supply chain disruptions; (32) risks to our business caused by the impacts of geopolitical events, such as the ongoing conflicts in the Middle East, including hostilities with Iran, the war between Russia and Ukraine, and other current or future conflicts; and (33) risks associated with maintaining our international operations, including unfavorable and uncertain regulatory, political, economic, tax, and labor conditions. The foregoing list of factors is not exhaustive and new factors may emerge from time to time that could also affect actual performance and results. For more information, please see the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025 and in Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2026. Actual results, performance or achievements may differ materially, and potentially adversely, from any forward-looking statements and the assumptions on which those forward-looking statements are based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as forward-looking statements are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond our control. All information set forth herein speaks only as of the date hereof, and we disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date hereof except as may be required under applicable securities laws. Forecasts and estimates regarding our industry and end markets are based on sources we believe to be reliable, however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.
3 Q3 2026 Overview Q3 Revenue Q3 Gross Profit & Gross Margin Revenue – Revenue decreased 62.8% Y/Y, primarily driven by a 62.2% reduction in sales volume. The decline reflected weaker sales across Europe and APAC as the result of softer end-market demand for heavy-duty trucks, port equipment, and heavy mining equipment, which led to reduced orders from several of our long-standing customers across Europe and APAC. The decrease in U.S. sales was primarily due to our largest customer bringing product into 2025 due to uncertainty around tariff outcomes. Gross Profit – Our gross profit margin was 5.2% for the three months ended September 30, 2026, compared to 37.6% in 2025. This change was primarily attributable to a $9.3 million write-down for obsolete inventories related to specialized ESS components and other inventories, which negatively impacted our gross margin by 20.4 percentage points. Revenue $45.8M Gross Margin 5.2% Adj. EBITDA -$60.8M Gross Profit $2.4M $38.6 $80.1 $101.4 $123.3 $45.8 2022 2023 2024 2025 2026 M IL LI O N S U SD $2.0 $17.9 $33.6 $46.4 $2.45. 2% 22 .3 % 33 .2 % 37 .6 % 5. 2% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% $0 $5 $10 $15 $20 $25 $30 $35 $40 $45 $50 2022 2023 2024 2025 2026 M IL LI O N S U SD Gross Profit Gross Margin
4 Q3 2026 P&L ($ in thousands) Revenue vs. Prior Year Period Revenue decreased 62.8% year-over-year (“Y/Y”), primarily driven by a reduction in sales volume from approximately 501.7 MWh in 2025 to approximately 189.6 MWh for the same period in 2026. Gross margin decreased to 5.2% compared to 37.6% in 2025, primarily due to a $9.3 million write-down for obsolete inventories, lower sales volume, continued pricing pressure and reduced fixed cost absorption. Operating Expenses vs. Prior Year Period G&A: Increase Y/Y primarily due to a $5.1M net provision for the proposed settlement of the Schelling Action (approximately $16.5M in total, subject to definitive documentation and court approval). R&D: Increase was primarily due to an increase in labor costs as we expanded our investment in new product development. S&M: Decrease was primarily due to lower personnel costs. Performance Net loss of $76.8M for the three-month period. EBITDA of negative $61.6M for the three-month period. Nine Months Ended Sept. 30 Three Months Ended Sept. 30GAAP Income Statement 2025202620252026 331,117193,679123,28745,805Revenue (205,242)(135,311)(72,151)(34,092)Cost of revenues (4,724)(11,067)(4,724)(9,346)Write-down for obsolete inventories 121,15147,30146,4122,367Gross Profit 36.6%24.4%37.6%5.2%Gross Margin (43,064)(47,198)(17,760)(20,371)General and administrative expenses (23,724)(26,032)(7,757)(8,362)Research and development expenses (16,229)(14,654)(6,006)(4,569)Selling and marketing expenses (1,400)(35,765)(36)(35,741)Impairment loss of long-lived assets (84,417)(123,649)(31,559)(69,043)Total operating expense 2,45527449Subsidy Income 39,189(76,321)14,897(66,667)Profit/(loss) from operations (91,002)58,001(12,641)-Change in fair value of warrants and convertible loan 8,951(15,377)(1,903)(3,772)Foreign exchange (loss) gain (1,936)(1,451)(1,103)(932)Others (44,798)(35,148)(750)(71,371)Net loss before income tax (959)(5,429)(739)(5,429)Income tax expense (45,757)(40,577)(1,489)(76,800)Net loss
5 Q3 2026 Revenue by Region ($ in thousands) Three Months Ended Sept. 30Revenue by region Y/Y %20252026 -65%38,81013,454APAC -64%77,90727,843Europe -31%6,5704,508USA -63%123,28745,805Total Three Months Ended Sept. 30 Nine Months Ended Sept. 30Revenue by region Y/Y %20252026 -51%136,51967,202APAC -30%176,842123,468Europe -83%17,7563,009USA -42%331,117193,679Total Nine Months Ended Sept. 30 Note: USA revenue was decreased by a $2.7 million tariff refund issued to a customer for the nine-month ended Sept. 30, 2026. 30% 60% 10% APAC Europe USA 0% 10% 20% 30% 40% 50% 60% 70% 2026 31% 64% 5% -10% 0% 10% 20% 30% 40% 50% 60% 70% APAC Europe USA 2025 34% 64% 2% 0% 10% 20% 30% 40% 50% 60% 70% APAC Europe USA 2026 42% 53% 5% APAC Europe USA -10% 0% 10% 20% 30% 40% 50% 60% 70% 2025
6 Cash Flow Statement ($ in thousands) Operating Cash Flow Net cash used in our operating activities was $65.4 million for the nine months ended September 30, 2026, compared to $59.5 million in cash generated by operating activities in the same period in 2025. The changes in our operating assets and liabilities were primarily driven by the decreases in notes payable, the decreases in accrued expenses and other liabilities and an increase in inventory balances, partially offset by a decrease in accounts receivable due to improved credit management. Investing Activities Net cash used in investing activities was $5.6 million for the nine months ended September 30, 2026, compared to $15.5 million in the same period of 2025. This cash outflow primarily consisted of $9.2 million for the purchase of an office building in Houston, $7.3 million for the acquisition of machinery and equipment, and other capital expenditures related to the expansion of our Huzhou Phase 3.2 manufacturing facility, partially offset by $10.8 million in proceeds from the sale of our Lake Mary, Florida facility (previously held for sale). Financing Activities $23.3M net inflow from refinancing and repayments. Foreign Exchange Impact $3.0M positive impact from exchange rate fluctuations. Cash Position Ended the period with $124.4M in cash, cash equivalents and restricted cash, a $44.8M decrease. Usable cash was ~$71.3M at Oct. 31, 2026. Nine Months Ended Sept. 30Condensed & Consolidated Cash Flow 2026 (40,577)GAAP net loss Operating activities: (58,001)Changes in fair value of warrant liability and convertible loan 53,141Other operating activities 24,775Depreciation 2,614Non-cash settled share-based compensation 52,320Net receivables (7,098)Inventory (92,615)Net liabilities & expenses (65,441)Net cash from operating activities Investing activities: (5,637)Net PP&E (5,637)Net cash from investing activities Financing activities: 97,113Net proceeds (73,801)Net repayments 23,312Net cash from financing activities 2,972Exchange rate changes (44,794)Decrease in cash, cash equivalents and restricted cash 169,238Cash, cash equivalents and restricted cash at beginning of the period 124,444Cash, cash equivalents and restricted cash at end of the period
T E C H N O L O G Y U P D A T E
8 Note: The results presented are preliminary, early-stage R&D prototype data obtained under limited laboratory or test conditions. They are not commercial qualification results and remain subject to further validation, repeat testing, scale-up, customer qualification, manufacturing readiness and capital availability. Energy, cycle-life and rate results come from different prototypes and do not define one commercial cell. ~72 V is a stack voltage reached in testing. All-Solid-State Battery Update Electrochemical Performance & Bipolar Integration Liquid-free architecture with results across separate development prototypes Liquid-free design: Microvast’s ASSB design uses no liquid electrolyte, unlike approaches that retain liquid catholyte. 366 Wh/kg complete-cell result: laboratory specific energy includes packaging and tabs. Safety testing: Selected fully charged prototypes showed no visible smoke or fire in separate 200°C hot-box and nail-penetration tests. Hot-box terminal voltage fell to 0 V after a pouch-related short. A separate ~15 V multilayer prototype powered a fan after corner cutting and pouch opening. Long-cycle development cell 17-layer bipolar prototype 1,323 79.58% cycles at 0.33C capacity retention ~72 V 81.6% Stack voltage retention at cycle 300 (0.33C) Figure 1. Separate long-cycle development cell. Figure 2. Bipolar cycling with original voltage profile inset.
9Note: The results presented are preliminary, early-stage R&D prototype data obtained under limited laboratory or test conditions. They are not commercial qualification results and remain subject to further validation, repeat testing, scale-up, customer qualification, manufacturing readiness and capital availability. All-Solid-State Battery Update Silicon–Sulfur Chemistry & Multilayer Architecture Sulfur-based chemistry and electrode-level dimensional compensation Sulfur cathode pathway: pairs sulfur with pre-lithiated silicon, offering an alternative to nickel- and cobalt-based cathode active materials. Separate five-layer study: summed cathode thickness increased 48.2 µm and summed anode thickness decreased 51.6 µm on discharge. Monolithic integration pathway: internal series stacking is a development direction for higher-voltage sulfur-based solid-state assemblies. Figure 1. Si–S pouch: initial 10 cycles. Opposing layer changes suggest partial compensation; these are not whole-cell swelling measurements. Figure 2. Separate five-layer SEM study: charged and discharged states.
10 Preserve liquidity, address near-term debt maturities and stabilize operations. Substantial doubt about our ability to continue as a going concern has not been alleviated. Outlook In light of the uncertainty regarding our liquidity position, our ongoing discussions with our lenders regarding the refinancing, extension or restructuring of our near-term debt obligations, and softer end-market demand, we are implementing operating cost reduction initiatives across all areas of the business, reducing or deferring certain discretionary capital expenditures and implementing targeted reductions in workforce in certain of our operations. Our cost-reduction program has not been fully implemented, and the cash costs associated with these actions have strained and may continue to strain our near-term liquidity. We continue to explore potential opportunities in the commercial vehicle market. Installation and commissioning of the Phase 3.2 production equipment at our Huzhou, China facility have been completed. Production ramp-up is dependent on customer demand, production yields, product qualification, operating efficiency and working capital availability. Unless production volumes increase sufficiently, the Phase 3.2 line will operate below its designed capacity. The pack assembly line at our Clarksville facility is substantially completed. Resumption of full-scale construction at the facility remains contingent upon securing additional financing or strategic partnerships.
A P P E N D I X
12 Non-GAAP Reconciliations ($ in thousands) Nine Months Ended Sept. 30Three Months Ended Sept. 30 2025202620252026 331,117193,679123,28745,805Revenues (205,242)(135,311)(72,151)(34,092)Cost of revenues (4,724)(11,067)(4,724)(9,346)Write-down for obsolete inventories 121,15147,30146,4122,367Gross profit (GAAP) 36.6%24.4%37.6%5.2%Gross margin 1841016029Non-cash settled share-based compensation (included in cost of revenues) 121,33547,40246,4722,396Adjusted gross profit (non-GAAP) 36.6%24.5%37.7%5.2%Adjusted gross margin (non-GAAP) Nine Months Ended Sept. 30Three Months Ended Sept. 30 2025202620252026 (43,064)(47,198)(17,760)(20,371)General and administrative expenses (23,724)(26,032)(7,757)(8,362)Research and development expenses (16,229)(14,654)(6,006)(4,569)Selling and marketing expenses (1,400)(35,765)(36)(35,741)Impairment loss of long-lived assets (84,417)(123,649)(31,559)(69,043)Operating expenses (GAAP) 2,0932,513668735Non-cash settled share-based compensation (included in Operating expenses) (82,324)(121,136)(30,891)(68,308)Adjusted operating expenses (non-GAAP)
13 Non-GAAP Reconciliations ($ in thousands) Nine Months Ended Sept. 30Three Months Ended Sept. 30 2025202620252026 (45,757)(40,577)(1,489)(76,800)Net loss (GAAP) 91,002(58,001)12,641-Changes in fair value of warrant and convertible loan* 2,2772,614728764Non-cash settled share-based compensation* 47,522(95,964)11,880(76,036)Adjusted net profit/(loss) (non-GAAP) *The tax effect of the adjustments was nil. Nine Months Ended Sept. 30Three Months Ended Sept. 30 2025202620252026 (45,757)(40,577)(1,489)(76,800)Net loss (GAAP) 3,0842,4341,019994Interest expense, net 9595,4297395,429Income tax expense 24,74725,3748,2728,815Depreciation and amortization (16,967)(7,340)8,541(61,562)EBITDA (non-GAAP) 91,002(58,001)12,641-Changes in fair value of warrant liability and convertible loan 2,2772,614728764Non-cash settled share-based compensation 76,312(62,727)21,910(60,798)Adjusted EBITDA (non-GAAP)